World Heart Summit 2026

Aim: The session aims to showcase how countries are scaling up hypertension control through concrete policy reforms, investments, and service delivery innovations, including efforts to address pregnancy-related hypertension and gender disparities in cardiovascular care, while encouraging ministers to highlight proven interventions and partnerships that have delivered measurable impact and can be replicated at scale.

Aim: The session aims to examine how environments, policies, and systemic factors shape population health behaviours, exploring strategies from behavioural “nudges” to fiscal measures like taxes that can drive meaningful cardiovascular health improvements at scale, while critically assessing whether current approaches risk treating symptoms rather than addressing underlying structural drivers.

Aim: This session will examine the global state of dyslipidaemia management and explore what is needed to translate recent progress into meaningful cardiovascular health gains. Dyslipidaemia remains a major cardiovascular risk factor, with high LDL-C responsible for over 30% of ischaemic heart disease. While momentum is building through initiatives such as WHO’s development of dyslipidaemia guidelines and the EU Safe Hearts call for expanded LDL-C testing and improved screening for Lp(a) and familial hypercholesterolaemia, persistent gaps in diagnosis, treatment, and health system capacity continue to limit impact – underscoring the need for coordinated, system-level action.

Aim: The session aims to explore how renewed global political commitments on NCDs, including cardiovascular disease, can be translated into measurable action, by strengthening accountability, national reporting, civil society engagement, and collaboration among global, regional, and national actors to ensure sustained implementation and real-world impact beyond the UN High-Level Meeting.